MSK Pulmo-Oncology Symposium 2025
Advancing Pulmonary Care in Oncology Patients
Overview
Pulmo-oncology is an emerging interdisciplinary field at the intersection of pulmonary medicine and oncology, addressing the complex respiratory complications encountered in patients with cancer. The respiratory system is frequently affected by direct tumor involvement, immune-mediated toxicities, radiation injury, and systemic anti-neoplastic therapies.
Now in its third year, the MSK Pulmo-Oncology Symposium brings together global experts from pulmonology, oncology, radiation oncology, surgery, and palliative care to present the latest advances in cancer therapies and best practices for the evaluation and management of pulmonary complications in cancer patients.
Key Program Topics
- State-of-the-art updates in lung cancer treatment
- Immune-mediated and therapy-related lung toxicities
- Prevention and management of complex pulmonary complications
- Multidisciplinary approaches to challenging clinical cases
Learning Objectives
- Define the role of the pulmonologist in cancer-related pulmonary complications
- Identify state-of-the-art diagnostic and treatment strategies for lung cancer
- Manage non-infectious pulmonary complications of stem cell transplantation
- Apply multidisciplinary strategies in complex oncology patients
- Implement symptom prevention and management strategies
- Recognize sleep-disordered breathing in cancer patients
Target Audience
This symposium is designed for healthcare professionals involved in the care of cancer patients with pulmonary conditions, including:
Pulmonology, Pulmonary Medicine, Medical Oncology, Hematology, Radiation Oncology, Thoracic Surgery, Thoracic Medical Oncology, Hospital Medicine, Infectious Diseases, Critical Care, Sleep Medicine, Palliative Care, Nurse Practitioners, Physician Assistants, Nursing, Respiratory Therapy, Pharmacology, and Integrative Medicine.
Scientific Program – Friday, September 19, 2025
| Time | Session | Faculty |
|---|---|---|
| 8:00–9:00 | Sleep Disordered Breathing in Cancer Patients | Miranda Tan, DO, FCCP |
| 9:00–9:25 | New Drugs and Combinations in Lung Cancer | Alissa Cooper, MD |
| 9:25–9:45 | Neoadjuvant Strategies: Surgical Perspective | Matthew Bott, MD |
| 9:45–10:05 | Novel Endobronchial Therapies | Rastko Rakocevic, MD |
| 10:05–10:25 | Radiation Pneumonitis & Multidisciplinary Care | Daniel Gomez, MD |
| 11:15–12:00 | Checkpoint Inhibitor-Related Pneumonitis | Karthik Suresh, MD |
| 1:00–1:25 | ADC & Targeted Therapy Lung Toxicity | Ajay Sheshadri, MD |
| 1:25–1:45 | Pulmonary Complications Post-HSCT | Andrew C. Harris, MD |
| 2:55–3:20 | Pulmonary Rehabilitation | Elizabeth Yogiaveetil, MD |
| 3:20–3:40 | Symptom Management | Craig D. Blinderman, MD |
| 3:40–4:00 | Health Education in the Social Media Era | Timothy Tiutan, MD |
| 4:00–4:25 | Tobacco Treatment in Cancer Care | Jamie Ostroff, PhD |
